References:
1. Zhou Y, Xue X, Shi P, Lu Q, Lv S. Multidisciplinary team management
of 46,XY 17α-hydroxylase deficiency: a case report and literature
review. J Int Med Res. 25 mars 2021;49(3):0300060521993965.
2. Kim SM, Rhee JH. A case of 17 alpha-hydroxylase deficiency. Clin Exp
Reprod Med. juin 2015;42(2):72‑6.
3. Wu C, Fan S, Qian Y, Zhou Y, Jin J, Dai Z, et al. 17α-Hydroxylase/17,
20-Lyase Deficiency: Clinical and Molecular Characterization of Eight
Chinese Patients. Endocr Pract. 1 mai 2017;23(5):576‑82.
4. Incidental diagnosis of 17 alpha-hydroxylase deficiency: a case
report | Oxford Medical Case Reports | Oxford Academic
[Internet]. [cité 11 août 2022]. Disponible sur:
https://academic.oup.com/omcr/article/2020/12/omaa108/6024565
5. Abacı A, Çatlı G, Berberoğlu M. Gonadal malignancy risk and
prophylactic gonadectomy in disorders of sexual development. J Pediatr
Endocrinol Metab JPEM. sept 2015;28(9‑10):1019‑27.
6. Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies,
genetic and pharmacologic. J Steroid Biochem Mol Biol. 1 janv
2017;165:71‑8.
7. Krone N, Reisch N, Idkowiak J, Dhir V, Ivison HE, Hughes BA, et al.
Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to
P450 Oxidoreductase Deficiency. J Clin Endocrinol Metab. févr
2012;97(2):E257‑67.